Caldwell Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Caldwell Trust's XBI Position: Q3 2026 in Review
Caldwell Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 600 shares worth $94.6K. The position accounts for 0.01% of the portfolio, ranked #418.
Caldwell Trust first reported a position in XBI in Q4 2019 and has held it in 28 quarters since. The position peaked at $214K in Q4 2020. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Caldwell Trust held 600 shares of State Street SPDR S&P Biotech ETF worth $94.6K as of Q3 2026.
- Caldwell Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Caldwell Trust's portfolio in Q3 2026, its #418 holding.
- Caldwell Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 28 quarters since.
- Caldwell Trust's State Street SPDR S&P Biotech ETF position peaked at $214K in Q4 2020.
- 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.